Letter
The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review

https://doi.org/10.1016/j.jaad.2015.12.052Get rights and content

First page preview

First page preview
Click to open first page preview

References (5)

There are more references available in the full text version of this article.

Cited by (0)

Funding sources: None.

Conflict of interest: None declared.

An abstract from this research has been accepted as an E-poster for presentation at the 2016 American Academy of Dermatology Annual Meeting.

This project was deemed exempt by institutional review board of the University of Utah (IRB # 075035).

View full text